Ari Kellen

Experienced Corporate Strategist and Change Leader

About Ari Kellen

Dr. Ari Kellen brings nearly 25 years of management experience in health care-related industries to the leadership team of Valeant Pharmaceuticals, where serves as an executive vice president overseeing the U.S. Dermatology, U.S. Bausch + Lomb, and Latin American arms of the group. Prior to joining Valeant, Dr. Ari Kellen was a senior partner with McKinsey & Compan. At McKinsey he developed a strong background in corporate strategy development and change management from 1991 to 2013.

In addition to advising top management teams of several North American health care firms on growth and turnaround plans, Dr. Ari Kellen also conducted numerous R&D and innovation studies. His work has been cited in the Harvard Business Review, the McKinsey Quarterly, the Globe and Mail, and other nationally distributed publications.

Dr. Kellen received his graduate education in medicine as well as business administration at the University of Witwatersrand in Johannesburg, South Africa. In addition to his professional background, he also has clinical experience in emergency trauma care and hospital management.